Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease

Parkinson’s disease (PD) is the second most common neurodegenerative disease characterized by motor dysfunction. Growing evidence has demonstrated that gut dysbiosis is involved in the occurrence, development and progression of PD. Numerous clinical trials have identified the characteristics of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Manlian, Liu, Xia, Ye, Yiru, Yan, Xiumei, Cheng, Yiwen, Zhao, Longyou, Chen, Feng, Ling, Zongxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263276/
https://www.ncbi.nlm.nih.gov/pubmed/35812394
http://dx.doi.org/10.3389/fimmu.2022.937555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263276/
https://www.ncbi.nlm.nih.gov/pubmed/35812394
http://dx.doi.org/10.3389/fimmu.2022.937555

Ejemplares similares